Scientists in the U.K., Australia and China have identified a brain molecule called NEAT1 that appears to play a central role ...

Individuals with type 1 (T1D) and type 2 diabetes have a higher risk for ischemic stroke, but those with T1D also have a higher risk for hemorrhagic stroke.

Trauma centers nationwide will begin to test a new approach for assessing traumatic brain injury (TBI) that is expected to lead to more accurate diagnoses and more appropriate treatment and follow-up ...

A concerning report from Diabetes UK reveals that nearly 29% of heart disease deaths in England now involve individuals with ...

Judy George covers neurology and neuroscience news for MedPage Today. She writes about brain aging, Alzheimer’s disease, dementia, MS, rare diseases, epilepsy, autism, headache, stroke ...

The 19-year-old infielder jumped from No. 88 to No. 23 in Baseball America’s Top 100 prospects list on Wednesday. The staggering 65-spot leap comes with the magazine’s first in-season update ...

“It was pressure. That’s the best word I’ve used to describe it — no pain and it didn’t even last super long.” A stroke occurs when blood flow to the brain is blocked or there is ...

An SUV going down a road in Paco, Manila hit a pedicab, crashed into a center island, and backed into another vehicle, with the driver apparently experiencing the symptoms of heat stroke. In EJ ...

There are certain lifestyle choices that can lower your risk of developing dementia, stroke and depression later ... Here are the top three practices that experts found have the greatest effect ...

Whether you’re recovering from an injury or stroke or dealing with the pain of fibromyalgia or another condition, you may benefit from a physical therapy procedure called electrical stimulation ...

Apple reported a decline in revenue for mainland China, Hong Kong and Taiwan for the quarter ended March 29, as the US tech giant continued to lose ground in the Chinese market amid a trade war ...

of the New England Institute for Neurology and Headache in Stamford, Connecticut, said in a statement. DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the ...